2019
DOI: 10.1097/aco.0000000000000736
|View full text |Cite
|
Sign up to set email alerts
|

The patient with hypertension and new guidelines for therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 48 publications
0
8
0
Order By: Relevance
“…There is a possibility that disease severity and the interventions subjects received are not the same. Whether nonpharmacological treatment or pharmacological therapy, the justification for treatment and the targets of management depend upon severity of the disease and the degree of organ damage [46,47]; while not all patients would get treatment goals. Future clinical research design should filter the enrolled subjects strictly, expand the sample size, and use subgroup analysis to explore the effects of these comorbidities and their intervention on cognitive function.…”
Section: Clinical Risk Factors For Preoperative Cognitive Impairmentmentioning
confidence: 99%
“…There is a possibility that disease severity and the interventions subjects received are not the same. Whether nonpharmacological treatment or pharmacological therapy, the justification for treatment and the targets of management depend upon severity of the disease and the degree of organ damage [46,47]; while not all patients would get treatment goals. Future clinical research design should filter the enrolled subjects strictly, expand the sample size, and use subgroup analysis to explore the effects of these comorbidities and their intervention on cognitive function.…”
Section: Clinical Risk Factors For Preoperative Cognitive Impairmentmentioning
confidence: 99%
“…It has been claimed that hypertensive patients may have greater cardiovascular lability and exaggerated hemodynamic stress response, particularly at the induction of anesthesia, due to increased catecholamine levels and increased sensitivity of peripheral vessels to catecholamines [ 26 ]. These blood pressure fluctuations may cause perioperative myocardial ischemia [ 27 ] and renal and cognitive impairment [ 28 ]. As a limitation of the present study, we did not analyze any intra- or postoperative data.…”
Section: Discussionmentioning
confidence: 99%
“…Perioperative management of ANG II-related medication is debated (21). Reducing ANG II has significant clinical relevance in managing hypertension and heart failure and angiotensin II type 1 receptor (AT 1 R) blockade has been shown to have renoprotective properties (22).…”
Section: Introductionmentioning
confidence: 99%